{"filings":[{"id":126503,"accession_number":"0001493152-25-025156","cik":1850767,"company_name":"Accustem Sciences Inc.","ticker":"ACUT","form_type":"8-K","filed_at":"2025-11-26T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"AccuStem submits Medicare coverage application for MSC lung cancer test; enters Novitas review","summary_kind":"llm","event_type":"regulatory","confidence":"high","bullets":["Submitted local coverage determination to Novitas Solutions for MSC test reimbursement.","Novitas confirmed application complete and valid; now in review queue for JL region (DC, DE, MD, NJ, PA).","MSC test analyzes 24 circulating microRNAs in plasma to classify lung nodule risk.","If approved, could reduce unnecessary biopsies for benign nodules and prioritize high-risk patients."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":4138608.9999999995,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":179539,"accession_number":"0001493152-25-000089","cik":1850767,"company_name":"Accustem Sciences Inc.","ticker":"ACUT","form_type":"8-K/A","filed_at":"2025-01-02T23:59:59+00:00","items":["4.01"],"status":"ready","headline":"AccuStem Sciences amends 8-K to correct name of independent accounting firm","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Amendment to Dec 30, 2024 8-K solely to revise the name of the independent registered public accounting firm.","Mercurius & Associates LLP (PCAOB No. 3223) was appointed on June 17, 2024.","No other modifications to the initial 8-K disclosure.","No prior consultations or disagreements with Mercurius before appointment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":4138608.9999999995,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":196266,"accession_number":"0001493152-24-052550","cik":1850767,"company_name":"Accustem Sciences Inc.","ticker":"ACUT","form_type":"8-K","filed_at":"2024-12-30T23:59:59+00:00","items":["4.01"],"status":"ready","headline":"AccuStem Sciences appoints Mercurius LLP as new auditor","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Mercurius LLP appointed as AccuStem Sciences' independent registered public accounting firm effective June 17, 2024.","No prior consultations with Mercurius regarding accounting principles or reportable events occurred during fiscal years 2022-2023.","8-K signed December 30, 2024, approximately six months after the appointment date."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":4138608.9999999995,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}